Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC.CRL · Entity 3398 | EVP & Chief People Officer | August 06, 2026 | August 10, 2026 |
| ITT INC.ITT · Entity 8806 | See Remarks | May 21, 2018 | May 22, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Report date August 06, 2026 · Filed August 10, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 30,051 |
Ending reported balance
After 2026-08-06 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-08-06 · Exercise / conversion · Acquired 4,179 · Balance 34,230 Row 2 · 2026-08-06 · Sale · Disposed 4,179 · Balance 30,051 |
| Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $179.66 · Expires 2030-05-29 | Direct | 0 |
Reported balance
After 2026-08-06 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-08-06 · Exercise / conversion · Disposed 4,179 · Balance 0 |
ITT INC.
Report date May 21, 2018 · Filed May 22, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 15,408.053 |
Last balance in matching sequence
After 2018-05-21 transaction · row 2
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 1 · 2018-05-21 · Exercise / conversion · Acquired 7,640 · Balance 23,048.053 F1: Includes 12.053 shares under a dividend reinvestment plan. Row 2 · 2018-05-21 · Sale · Disposed 7,640 · Balance 15,408.053 F2: This price represents the approximate weighted average price per share of sales of common stock of ITT Inc. (the "Issuer"), which were executed at prices ranging from $55.13 to $55.19 per share. The reporting person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price. F1: Includes 12.053 shares under a dividend reinvestment plan. |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $41.52 · Expires 2025-02-25 | Direct | 0 |
Reported balance
After 2018-05-21 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2018-05-21 · Exercise / conversion · Disposed 7,640 · Balance 0 |
Filing footnotes · ownership attribution and instrument terms
F1: Includes 12.053 shares under a dividend reinvestment plan.
F2: This price represents the approximate weighted average price per share of sales of common stock of ITT Inc. (the "Issuer"), which were executed at prices ranging from $55.13 to $55.19 per share. The reporting person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 06, 2026 Filed Aug 10, 2026 20:35 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionStock Options (Right to Buy) · Derivative | 4,179 | $0.00 Strike: $179.66 | $0.00 |
DisclosureSEC source: 0001100682-26-000122 · form4.xml · derivative · entry 3 Creamer Victoria L · CIK 0001632780 · EVP & Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,179 shares Expires 2030-05-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 06, 2026 Filed Aug 10, 2026 20:35 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 4,179 | $259.16 | $1,083,029.64 |
DisclosureSEC source: 0001100682-26-000122 · form4.xml · nonDerivative · entry 2 Creamer Victoria L · CIK 0001632780 · EVP & Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,051 Read SEC document |
| August 06, 2026 Filed Aug 10, 2026 20:35 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionCommon Stock | 4,179 | $179.66 | $750,799.14 |
DisclosureSEC source: 0001100682-26-000122 · form4.xml · nonDerivative · entry 1 Creamer Victoria L · CIK 0001632780 · EVP & Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,230 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 31, 2026 Filed Jun 2, 2026 20:27 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 194 | $180.71 | $35,057.74 |
DisclosureSEC source: 0001100682-26-000089 · form4.xml · nonDerivative · entry 3 Creamer Victoria L · CIK 0001632780 · EVP & Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,051 Read SEC document |
| May 30, 2026 Filed Jun 2, 2026 20:27 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 616 | $180.71 | $111,317.36 |
DisclosureSEC source: 0001100682-26-000089 · form4.xml · nonDerivative · entry 2 Creamer Victoria L · CIK 0001632780 · EVP & Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,245 Read SEC document |
| May 29, 2026 Filed Jun 2, 2026 20:27 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantCommon Stock | 5,135 | $180.71 | $927,945.85 |
DisclosureSEC source: 0001100682-26-000089 · form4.xml · nonDerivative · entry 1 Creamer Victoria L · CIK 0001632780 · EVP & Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,861 F1 · shares: Unvested restricted stock units annually ratably vest on: May 29, 2027; May 29, 2028; May 29, 2029; May 29, 2030. Read SEC document |
| May 27, 2026 Filed May 28, 2026 20:43 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 148 | $156.73 | $23,196.04 |
DisclosureSEC source: 0001100682-26-000085 · form4.xml · nonDerivative · entry 2 Creamer Victoria L · CIK 0001632780 · EVP & Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,726 Read SEC document |
| May 26, 2026 Filed May 28, 2026 20:43 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 198 | $160.30 | $31,739.40 |
DisclosureSEC source: 0001100682-26-000085 · form4.xml · nonDerivative · entry 1 Creamer Victoria L · CIK 0001632780 · EVP & Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,874 Read SEC document |
| January 30, 2026 Filed Feb 3, 2026 21:33 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 1,296 | $211.68 | $274,337.28 |
DisclosureSEC source: 0001100682-26-000014 · form4.xml · nonDerivative · entry 2 Creamer Victoria L · CIK 0001632780 · EVP & Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,072 Read SEC document |
| January 30, 2026 Filed Feb 3, 2026 21:33 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantCommon Stock | 5,006 | $0.00 | $0.00 |
DisclosureSEC source: 0001100682-26-000014 · form4.xml · nonDerivative · entry 1 Creamer Victoria L · CIK 0001632780 · EVP & Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,368 F1 · shares: Reflects shares of common stock issued following the achievement of performance goals set forth in performance share unit awards originally granted on May 26, 2023. Read SEC document |
| May 31, 2025 Filed Jun 3, 2025 20:49 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 120 | $135.63 | $16,275.60 |
DisclosureSEC source: 0001127602-25-016542 · form4.xml · nonDerivative · entry 2 Creamer Victoria L · CIK 0001632780 · EVP & Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,362 Read SEC document |
| May 30, 2025 Filed Jun 3, 2025 20:49 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantCommon Stock | 6,252 | $135.63 | $847,958.76 |
DisclosureSEC source: 0001127602-25-016542 · form4.xml · nonDerivative · entry 1 Creamer Victoria L · CIK 0001632780 · EVP & Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,482 F1 · shares: Unvested restricted stock units vest annually on: May 30, 2026; May 30, 2027; May 30, 2028; May 30, 2029. Read SEC document |
| May 28, 2025 Filed May 29, 2025 20:54 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 62 | $138.65 | $8,596.30 |
DisclosureSEC source: 0001127602-25-015892 · form4.xml · nonDerivative · entry 3 Creamer Victoria L · CIK 0001632780 · EVP & Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,230 Read SEC document |
| May 27, 2025 Filed May 29, 2025 20:54 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 91 | $136.73 | $12,442.43 |
DisclosureSEC source: 0001127602-25-015892 · form4.xml · nonDerivative · entry 2 Creamer Victoria L · CIK 0001632780 · EVP & Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,292 Read SEC document |
| May 26, 2025 Filed May 29, 2025 20:54 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 123 | $136.73 | $16,817.79 |
DisclosureSEC source: 0001127602-25-015892 · form4.xml · nonDerivative · entry 1 Creamer Victoria L · CIK 0001632780 · EVP & Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,383 Read SEC document |
| January 31, 2025 Filed Feb 3, 2025 21:25 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 791 | $165.57 | $130,965.87 |
DisclosureSEC source: 0001127602-25-002716 · form4.xml · nonDerivative · entry 2 Creamer Victoria L · CIK 0001632780 · EVP & Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,506 Read SEC document |
| January 31, 2025 Filed Feb 3, 2025 21:25 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantCommon Stock | 2,468 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-002716 · form4.xml · nonDerivative · entry 1 Creamer Victoria L · CIK 0001632780 · EVP & Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,297 F1 · shares: Reflects shares of common stock issued following the achievement of performance goals set forth in performance share unit awards originally granted on May 27, 2022. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 20:23 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantStock Options (Right to Buy) · Derivative | 4,470 | $208.44 Strike: $208.44 | $931,726.80 |
DisclosureSEC source: 0001127602-24-017680 · form4.xml · derivative · entry 2 Creamer Victoria L · CIK 0001632780 · EVP & Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,470 Underlying: Common Stock · 4,470 shares Expires 2034-05-31 F2 · shares: Stock options vest as follows: 1,117 on May 31, 2025, 1,118 on May 31, 2026, 1,117 on May 31, 2027, and 1,118 on May 31, 2028. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 20:23 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantCommon Stock | 1,967 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-017680 · form4.xml · nonDerivative · entry 1 Creamer Victoria L · CIK 0001632780 · EVP & Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,829 F1 · shares: Unvested restricted stock units vest as follows: 491 on May 31, 2025, 492 on May 31, 2026, 492 on May 31, 2027, and 492 on May 31, 2028. Read SEC document |
| May 29, 2024 Filed May 29, 2024 21:48 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 190 | $214.51 | $40,756.90 |
DisclosureSEC source: 0001127602-24-016820 · form4.xml · nonDerivative · entry 1 Creamer Victoria L · CIK 0001632780 · EVP & Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,947 Read SEC document |
| May 28, 2024 Filed May 29, 2024 21:08 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 77 | $217.21 | $16,725.17 |
DisclosureSEC source: 0001127602-24-016789 · form4.xml · nonDerivative · entry 3 Creamer Victoria L · CIK 0001632780 · EVP & Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,137 Read SEC document |
| May 28, 2024 Filed May 31, 2024 00:02 UTC Amendment | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 114 | $217.21 | $24,761.94 |
DisclosureSEC source: 0001127602-24-017057 · form4a.xml · nonDerivative · entry 3 Creamer Victoria L · CIK 0001632780 · EVP & Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,052 Read SEC document |
| May 27, 2024 Filed May 29, 2024 21:08 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 122 | $217.21 | $26,499.62 |
DisclosureSEC source: 0001127602-24-016789 · form4.xml · nonDerivative · entry 2 Creamer Victoria L · CIK 0001632780 · EVP & Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,214 Read SEC document |
| May 27, 2024 Filed May 31, 2024 00:02 UTC Amendment | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 170 | $217.21 | $36,925.70 |
DisclosureSEC source: 0001127602-24-017057 · form4a.xml · nonDerivative · entry 2 Creamer Victoria L · CIK 0001632780 · EVP & Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,166 Read SEC document |
| May 26, 2024 Filed May 29, 2024 21:08 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 180 | $217.21 | $39,097.80 |
DisclosureSEC source: 0001127602-24-016789 · form4.xml · nonDerivative · entry 1 Creamer Victoria L · CIK 0001632780 · EVP & Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,336 Read SEC document |
| May 26, 2024 Filed May 31, 2024 00:02 UTC Amendment | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 180 | $217.21 | $39,097.80 |
DisclosureSEC source: 0001127602-24-017057 · form4a.xml · nonDerivative · entry 1 Creamer Victoria L · CIK 0001632780 · EVP & Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,336 Read SEC document |
| February 29, 2024 Filed Mar 1, 2024 22:37 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 5,000 | $253.70 | $1,268,500.00 |
DisclosureSEC source: 0001127602-24-007955 · form4.xml · nonDerivative · entry 1 Creamer Victoria L · CIK 0001632780 · EVP & Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,550 Read SEC document |
| January 29, 2024 Filed Jan 31, 2024 22:26 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 953 | $220.28 | $209,926.84 |
DisclosureSEC source: 0001127602-24-002797 · form4.xml · nonDerivative · entry 2 Creamer Victoria L · CIK 0001632780 · EVP & Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,550 Read SEC document |
| January 29, 2024 Filed Jan 31, 2024 22:26 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantCommon Stock | 2,997 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-002797 · form4.xml · nonDerivative · entry 1 Creamer Victoria L · CIK 0001632780 · EVP & Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,503 F1 · shares: Reflects shares of common stock issued following the achievement of performance goals set forth in performance share unit awards originally granted on May 28, 2021. Read SEC document |
| January 29, 2024 Filed Mar 25, 2024 23:00 UTC Amendment | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 924 | $220.28 | $203,538.72 |
DisclosureSEC source: 0001127602-24-011130 · form4a.xml · nonDerivative · entry 2 Creamer Victoria L · CIK 0001632780 · EVP & Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,516 Read SEC document |
| January 29, 2024 Filed Mar 25, 2024 23:00 UTC Amendment | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantCommon Stock | 2,934 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-011130 · form4a.xml · nonDerivative · entry 1 Creamer Victoria L · CIK 0001632780 · EVP & Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,440 F1 · shares: Reflects shares of common stock issued following the achievement of performance goals set forth in performance share unit awards originally granted on May 28, 2021. Read SEC document |
| December 14, 2023 Filed Dec 18, 2023 21:07 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionStock Options (Right to Buy) · Derivative | 2,145 | $0.00 Strike: $124.13 | $0.00 |
DisclosureSEC source: 0001127602-23-029809 · form4.xml · derivative · entry 5 Creamer Victoria L · CIK 0001632780 · EVP & Chief People Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,145 shares Expires 2024-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 14, 2023 Filed Dec 18, 2023 21:07 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionStock Options (Right to Buy) · Derivative | 3,381 | $0.00 Strike: $144.67 | $0.00 |
DisclosureSEC source: 0001127602-23-029809 · form4.xml · derivative · entry 4 Creamer Victoria L · CIK 0001632780 · EVP & Chief People Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,381 shares Expires 2024-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 14, 2023 Filed Dec 18, 2023 21:07 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 5,526 | $225.00 | $1,243,350.00 |
DisclosureSEC source: 0001127602-23-029809 · form4.xml · nonDerivative · entry 3 Creamer Victoria L · CIK 0001632780 · EVP & Chief People Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 16,506 F1 · kind: This sale occurred pursuant to a Rule 10b5-1 Trading Plan that was initially adopted on August 16, 2023. Read SEC document |
| December 14, 2023 Filed Dec 18, 2023 21:07 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionCommon Stock | 2,145 | $124.13 | $266,258.85 |
DisclosureSEC source: 0001127602-23-029809 · form4.xml · nonDerivative · entry 2 Creamer Victoria L · CIK 0001632780 · EVP & Chief People Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 22,032 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 14, 2023 Filed Dec 18, 2023 21:07 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionCommon Stock | 3,381 | $144.67 | $489,129.27 |
DisclosureSEC source: 0001127602-23-029809 · form4.xml · nonDerivative · entry 1 Creamer Victoria L · CIK 0001632780 · EVP & Chief People Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 19,887 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 29, 2023 Filed May 31, 2023 17:18 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 190 | $194.12 | $36,882.80 |
DisclosureSEC source: 0001127602-23-017129 · form4.xml · nonDerivative · entry 4 Creamer Victoria L · CIK 0001632780 · EVP & Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,506 Read SEC document |
| May 28, 2023 Filed May 31, 2023 17:18 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 115 | $194.12 | $22,323.80 |
DisclosureSEC source: 0001127602-23-017129 · form4.xml · nonDerivative · entry 3 Creamer Victoria L · CIK 0001632780 · EVP & Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,696 Read SEC document |
| May 27, 2023 Filed May 31, 2023 17:18 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 170 | $194.12 | $33,000.40 |
DisclosureSEC source: 0001127602-23-017129 · form4.xml · nonDerivative · entry 2 Creamer Victoria L · CIK 0001632780 · EVP & Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,811 Read SEC document |
| May 26, 2023 Filed May 31, 2023 17:18 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantStock Options (Right to Buy) · Derivative | 4,820 | $194.12 Strike: $194.12 | $935,658.40 |
DisclosureSEC source: 0001127602-23-017129 · form4.xml · derivative · entry 5 Creamer Victoria L · CIK 0001632780 · EVP & Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,820 Underlying: Common Stock · 4,820 shares Expires 2033-05-26 F2 · shares: Stock Options vest as follows: 1,205 on May 26, 2024, 1,205 on May 26, 2025, 1,205 on May 26, 2026 and 1,205 on May 26, 2027. Read SEC document |
| May 26, 2023 Filed May 31, 2023 17:18 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantCommon Stock | 2,009 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-017129 · form4.xml · nonDerivative · entry 1 Creamer Victoria L · CIK 0001632780 · EVP & Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,981 F1 · shares: Restricted Stock Units vest as follows: 502 on May 26, 2024, 502 on May 26, 2025, 502 on May 26, 2026 and 503 on May 26, 2027. Read SEC document |
| February 22, 2023 Filed Feb 22, 2023 22:17 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 181 | $243.60 | $44,091.60 |
DisclosureSEC source: 0001127602-23-006545 · form4.xml · nonDerivative · entry 2 Creamer Victoria L · CIK 0001632780 · EVP & Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,972 Read SEC document |
| February 01, 2023 Filed Feb 22, 2023 22:17 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 343 | $248.21 | $85,136.03 |
DisclosureSEC source: 0001127602-23-006545 · form4.xml · nonDerivative · entry 1 Creamer Victoria L · CIK 0001632780 · EVP & Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,153 Read SEC document |
| January 31, 2023 Filed Jan 30, 2023 23:03 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 2,692 | $244.29 | $657,628.68 |
DisclosureSEC source: 0001127602-23-002705 · form4.xml · nonDerivative · entry 2 Creamer Victoria L · CIK 0001632780 · EVP & Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,496 Read SEC document |
| January 27, 2023 Filed Jan 30, 2023 23:03 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantCommon Stock | 7,229 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-002705 · form4.xml · nonDerivative · entry 1 Creamer Victoria L · CIK 0001632780 · EVP & Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,188 F1 · shares: Reflects shares of common stock issued following the achievement of performance goals set forth in performance share unit awards originally granted on May 29, 2020. Read SEC document |
| May 29, 2022 Filed May 31, 2022 22:08 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 190 | $244.41 | $46,437.90 |
DisclosureSEC source: 0001127602-22-016060 · form4.xml · nonDerivative · entry 3 Creamer Victoria L · CIK 0001632780 · EVP & Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,959 Read SEC document |
| May 28, 2022 Filed May 31, 2022 22:08 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 114 | $244.41 | $27,862.74 |
DisclosureSEC source: 0001127602-22-016060 · form4.xml · nonDerivative · entry 2 Creamer Victoria L · CIK 0001632780 · EVP & Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,149 Read SEC document |
| May 27, 2022 Filed May 31, 2022 22:08 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantStock Options (Right to Buy) · Derivative | 4,036 | $244.41 Strike: $244.41 | $986,438.76 |
DisclosureSEC source: 0001127602-22-016060 · form4.xml · derivative · entry 4 Creamer Victoria L · CIK 0001632780 · EVP & Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,036 Underlying: Common Stock · 4,036 shares Expires 2032-05-27 F2 · shares: Stock Options vest as follows: 1,009 on May 27, 2023, 1,009 on May 27, 2024, 1,009 on May 27, 2025 and 1,009 on May 27, 2026. Read SEC document |
| May 27, 2022 Filed May 31, 2022 22:08 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantCommon Stock | 1,493 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-016060 · form4.xml · nonDerivative · entry 1 Creamer Victoria L · CIK 0001632780 · EVP & Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,263 F1 · shares: Unvested restricted stock units vest as follows: 373 on May 27, 2023, 373 on May 27, 2024, 373 on May 27, 2025 and 374 on May 27, 2026. Read SEC document |
| February 22, 2022 Filed Feb 23, 2022 21:17 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 180 | $293.61 | $52,849.80 |
DisclosureSEC source: 0001127602-22-006270 · form4.xml · nonDerivative · entry 1 Creamer Victoria L · CIK 0001632780 · EVP & Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,770 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.